Shusaku Omoto

428 total citations
48 papers, 269 citations indexed

About

Shusaku Omoto is a scholar working on Neurology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shusaku Omoto has authored 48 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 11 papers in Epidemiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shusaku Omoto's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (14 papers) and Acute Ischemic Stroke Management (6 papers). Shusaku Omoto is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (14 papers) and Acute Ischemic Stroke Management (6 papers). Shusaku Omoto collaborates with scholars based in Japan and United States. Shusaku Omoto's co-authors include Yasuyuki Iguchi, Hidetomo Murakami, Tadashi Umehara, Soichiro Mochio, Tomotaka Shiraishi, Masaki Ueno, Toshihide Yamashita, Toshiyuki Takai, Takeo Sato and Teppei Komatsu and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Atherosclerosis.

In The Last Decade

Shusaku Omoto

39 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shusaku Omoto Japan 9 111 87 44 41 36 48 269
Vitalie Văcăraș Romania 10 64 0.6× 64 0.7× 21 0.5× 50 1.2× 75 2.1× 53 347
Sogol Meknatkhah Iran 8 54 0.5× 78 0.9× 29 0.7× 25 0.6× 32 0.9× 15 333
Pan‐Woo Ko South Korea 10 157 1.4× 109 1.3× 18 0.4× 19 0.5× 101 2.8× 22 371
Maryam Anzabi Denmark 6 108 1.0× 35 0.4× 11 0.3× 38 0.9× 49 1.4× 8 305
Salvatore Iacono Italy 10 125 1.1× 42 0.5× 17 0.4× 18 0.4× 38 1.1× 35 338
Donna M. Geddes‐Klein United States 7 130 1.2× 125 1.4× 34 0.8× 97 2.4× 40 1.1× 7 329
Shaobing Dai China 10 114 1.0× 151 1.7× 20 0.5× 15 0.4× 49 1.4× 20 319
Wenwei Yun China 11 76 0.7× 91 1.0× 16 0.4× 78 1.9× 108 3.0× 35 357
Guzal Khayrullina United States 11 77 0.7× 74 0.9× 36 0.8× 33 0.8× 136 3.8× 21 437
Anda Eilam Israel 8 49 0.4× 91 1.0× 9 0.2× 49 1.2× 40 1.1× 15 338

Countries citing papers authored by Shusaku Omoto

Since Specialization
Citations

This map shows the geographic impact of Shusaku Omoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusaku Omoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusaku Omoto more than expected).

Fields of papers citing papers by Shusaku Omoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shusaku Omoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusaku Omoto. The network helps show where Shusaku Omoto may publish in the future.

Co-authorship network of co-authors of Shusaku Omoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shusaku Omoto. A scholar is included among the top collaborators of Shusaku Omoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusaku Omoto. Shusaku Omoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omoto, Shusaku, et al.. (2026). Zonisamide-induced pleural effusion and agranulocytosis: a case report of a rare adverse reaction. Neurological Sciences. 47(1). 89–89.
2.
Murakami, Hidetomo, Tomotaka Shiraishi, Tadashi Umehara, et al.. (2025). Sleep disturbance is associated with worsening quality of life in patients with multiple system atrophy. Clinical Neurology and Neurosurgery. 250. 108794–108794.
3.
Murakami, Hidetomo, Tomotaka Shiraishi, Tadashi Umehara, et al.. (2025). Putamen dopaminergic dysfunction is associated with sleep disturbance in drug-naïve patients with Parkinson's disease. Sleep Medicine. 129. 82–88.
4.
Umehara, Tadashi, Tomotaka Shiraishi, Takeo Sato, et al.. (2024). Serum phosphorus levels associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease. Journal of the Neurological Sciences. 464. 123165–123165. 1 indexed citations
5.
Umehara, Tadashi, Tomotaka Shiraishi, Takeo Sato, et al.. (2024). Peripheral immune profile in drug-naïve dementia with Lewy bodies. Journal of Neurology. 271(7). 4146–4157. 1 indexed citations
8.
Murakami, Hidetomo, Tomotaka Shiraishi, Takeo Sato, et al.. (2022). Dysfunction in the right putamen is associated with drooling in de novo Parkinson's disease. SHILAP Revista de lepidopterología. 3(1). 100116–100116. 1 indexed citations
9.
Hayashi, Takaaki, et al.. (2022). Polypoidal choroidal vasculopathy in a patient with DMPK-associated myotonic dystrophy. Documenta Ophthalmologica. 144(3). 217–226. 1 indexed citations
10.
Komatsu, Teppei, Nobuyuki Sasaki, Hiroyuki Kida, et al.. (2022). Effects and safety of high-frequency rTMS in acute intracerebral hemorrhage patients: A pilot study. Journal of the Neurological Sciences. 443. 120473–120473. 10 indexed citations
12.
Komatsu, Teppei, Shusaku Omoto, Takeo Sato, et al.. (2021). A case of idiopathic hypertrophic pachymeningitis with high adenosine deaminase in cerebrospinal fluid. Clinical Neurology and Neurosurgery. 211. 107056–107056.
13.
Sato, Takeo, Kenichiro Sakai, Tomotaka Shiraishi, et al.. (2021). Employment Status Prior to Ischemic Stroke and Weekly Variation of Stroke Onset. Journal of Stroke and Cerebrovascular Diseases. 30(8). 105873–105873. 2 indexed citations
14.
Umehara, Tadashi, Hisayoshi Oka, Tomotaka Shiraishi, et al.. (2020). Sympathetic nervous activity and hemoglobin levels in de novo Parkinson’s disease. Clinical Autonomic Research. 30(3). 273–278. 6 indexed citations
15.
Umehara, Tadashi, Hisayoshi Oka, Tomotaka Shiraishi, et al.. (2020). Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson’s Disease. Journal of Parkinson s Disease. 11(2). 665–673. 8 indexed citations
16.
Sato, Takeo, Kenichiro Sakai, Teppei Komatsu, et al.. (2020). Convexity Subarachnoid Hemorrhage Accompanied by Hyperacute Ischemic Stroke. Cerebrovascular Diseases. 49(1). 70–78. 7 indexed citations
17.
Omoto, Shusaku, Eri Mori, Kouki Fujioka, et al.. (2017). A novel device for estimating olfactory threshold for differential diagnosis of parkinsonian syndrome: A pilot study. Journal of the Neurological Sciences. 381. 722–722. 1 indexed citations
18.
Omoto, Shusaku, et al.. (2016). Common Carotid Artery Stump Syndrome Due to Mobile Thrombus Detected by Carotid Duplex Ultrasonography. Journal of Stroke and Cerebrovascular Diseases. 25(10). e205–e207. 5 indexed citations
19.
Yogo, Makiko, Shusaku Omoto, Masayo Morita, & Masahiko Suzuki. (2015). The quantitative motion analysis using portable gait rhythmogram after CSF drainage in the patients with idiopathic normal pressure hydrocephalus. Fluids and Barriers of the CNS. 12(Suppl 1). P57–P57. 2 indexed citations
20.
Omoto, Shusaku, Masaki Ueno, Soichiro Mochio, & Toshihide Yamashita. (2010). Corticospinal tract fibers cross the ephrin-B3-negative part of the midline of the spinal cord after brain injury. Neuroscience Research. 69(3). 187–195. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026